Cerus (CERS) Says CBC Submitted BLA to FDA for Interstate Export of INTERCEPT Platelet Components
Tweet Send to a Friend
Cerus Corporation (Nasdaq: CERS) announced that The Community Blood Center (CBC) of Appleton, Wisconsin has submitted the first Biologics License ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
